Harm reduction associated with inhalation and oral administration of Cannabis and THC

Cannabis Therapeutics in HIV/AIDS

Volumn , Issue , 2012, Pages 133-152

  Grotenhermen, Franjo ^a  

^a Nova Institut   (Germany)

Author keywords

Cancer; Cannabinoids; Cannabis; Dosing; Harm reduction; Health risk; Inhalation; Marijuana; Opiates; Opium; Oral use; Overdose; Pharmacokinetics; Rectal use; Side effects; Smoking; Spontaneous pneumothorax; Sublingual use; THC; Therapeutic use; Transdermal use

Indexed keywords

EID: 85071416243     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (62)

1. Abrams, D.I., R.J. Leiser, S.B. Shade, J. Hilton, and T. Elbeik. 2000. Short-term effects of cannabinoids on HIV-1 viral load. Poster presented at the 13th International AIDS Conference in Durban/South Africa, 13th of July 2000
2. Anderson, P.F., D.M. Jackson, G.B. Chesher, and R. Malor. 1975. Tolerance to the effect of delta-9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity. Psychopharmacologia 43(1):31-36
3. Azorlosa, J.L., M.K. Greenwald, and M.L. Stitzer. 1995. Marijuana smoking: effects of varying puff volume and breathhold duration. J Pharmacol Exp Ther 272(2): 560-569
4. Bast, G. E. 1997. Influence of solubility and permeant size on absorption and metabolism of xenobiotics in rabbit skin. Hum Exp Toxicol 16:435-440
5. Beal, J.E., R. Olson, L. Laubenstein, J.O. Morales, P. Bellman, B. Yangco, L. Lefkowitz, T.F. Plasse, and K.V. Shepard. 1995. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manag 10(2):89-97
6. Beal, J.E., R. Olson, L. Lefkowitz, L. Laubenstein, P. Bellman, B. Yangco, J.O. Morales, R. Murphy, W. Powderly, T.F. Plasse, K.W. Mosdell, and K.V. Shepard. 1997. Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manag 14(1):7-14
7. Benowitz, N.L., and R.T. Jones. 1975. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther 18(3):287-297
8. Bloom, J.W., W.T. Kaltenborn, P. Paoletti, A. Camilli, and M.D. Lebowitz. 1987. Respiratory effects of non-tobacco cigarettes. Br Med J 295:1516-1518
9. Brenneisen R. 1984. Psychotrope Drogen. II. Bestimmung der Cannabinoide in Cannabis sativa L. und in Cannabisprodukten mittels Hochdruckflüssigkeitschromatographie (HPLC). Pharm Acta Helv 59(9-10):247-259
10. Brenneisen, R., A. Egli, M.A. ElSohly, V. Henn, and Y. Spiess. 1996. The effect of orally and rectally administered δ9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. Int J Clin Pharmacol Ther 34(10):446-452
11. Chesher, G.B., K.D. Bird, D.M. Jackson, A. Perrignon, and G.A. Starmer. 1990. The effects of orally administered delta 9-tetrahydrocannabinol in man on mood and performance measures: a dose-response study. Pharmacol Biochem Behav 35(4): 861-864
12. Cleary, J.F. 1997. Pharmacokinetic and pharmacodynamic issues in the treatment of breakthrough pain. Semin Oncol 24(5 Suppl 16):13-19
13. Conant, M., D. Roy, K.V. Shepard, and T.F. Plasse. 1991. Dronabinol enhances appetite and controls weight loss in HIV patients. Proc Annu Meet Am Soc Clin Oncol 10:A9
14. Davis, K.H., I.A. McDaniel, L.W. Cardwell, and P.L. Moody. 1984. Some smoking characteristics of marijuana cigarettes. In: Agurell, S., W.L. Dewey, and R.E. Willette. eds. The cannabinoids: Chemical, pharmacologic, and therapeutic aspects. New York: Academic Press, pp. 97-109
15. ElSohly, M.A., S.A. Ross, Z. Mehmedic, R. Arafat, B. Yi, and B.F. Banahan, 3rd. 2000. Potency trends of delta 9-THC and other cannabinoids in confiscated marijuana from 1980-1997. J Forensic Sci 45(1):24-30
16. Elsohly, M.A., T.L. Little, Jr., A. Hikal, E. Harland, D.F. Stanford, and L. Walker. 1991. Rectal bioavailability of delta-9-tetrahydrocannabinol from various esters. Pharmacol Biochem Behav 40(3):497-502
17. Fairbairn, J.W., J.A. Liebmann, and M.G. Rowan. 1976. The stability of cannabis and its preparations on storage. J Pharm Pharmacol 28(1):1-7
18. Feldman, A., J.T. Sullivan, M.A. Passero, and D.C. Lewis. 1993. Pneumothorax in polysubstance abusing marijuana and tobacco smokers: 3 cases. J Subst Abuse 5(2):183-186
19. Fligiel, S.E.G., M.D. Roth, E.C. Kleerup, S.H. Barsky, M.S. Simmons, and D.P. Tashkin. 1997. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana and/or tobacco. Chest 112(2):319-326
20. Frytak, S., C.G. Moertel, and J. Rubin. 1984. Metabolic studies of delta-9-tetrahydrocannabinol in cancer patients. Cancer Treat Rep 68(12):1427-1431
21. Frytak, S., C.G. Moertel, J.R. O'Fallon, J. Rubin, E.T. Creagan, M.J. O'Connell, A.J. Schutt, and N.W. Schwartau. 1979. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Ann Intern Med 91(6):825-830
22. Gieringer, D. 1996. Marijuana research: Waterpipe study. Bull Multidisc Assoc Psychedel Stud 6(3):59-66
23. Gieringer, D. 2000. Marijuana water pipe and vaporizer study. California NORML, San Francisco. http://www.maps.org/news-letters/v06n3/06359mj1.html
24. Gieringer, D. California NORML Press Release, January 7, 2001
25. Gormeley, M. 2000. Associated Press. January 21
26. Gorter, R., M. Seefried, and P. Volberding. 1992. Dronabinol effects on weight in patients with HIV infection. AIDS 6(1):127
27. Guy G.W., and M.E. Flint. A phase one study of sublingual cannabis based medicinal extracts. 2000 Symposium on the Cannabinoids, Burlington, Vermont: International Cannabinoid Research Society, p. 115
28. Hadgraft, J. 1996. Recent developments in topical and transdermal delivery. Eur J Drug Metab Pharmacokinet 21:165-173
29. Hall, W., and N. Solowij. 1998. Adverse effects of cannabis. Lancet 352(9140): 1611-1616
30. Hall, W., R. Room, and S. Bondy. 1999. Comparing the health and psychological risks of alcohol, cannabis nicotine and opiate use. In: H. Kalant, W. Corrigan, W. Hall, and R. Smart (eds.). The health effects of cannabis. Toronto: Addiction Research Foundation, pp. 477-508
31. Holdcroft, A., M. Smith, A. Jacklin, H. Hodgson, B. Smith, M. Newton, and F. Evans. 1997. Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia 52(5):483-486
32. Huber, G.L., and V.K. Mahajan. 1987. The comparative response of the lung to marihuana or tobacco smoke inhalation. In: Chesher, Greg, Paul Consroe, and Richard Musty. eds. Marijuana: An international research report. Proceedings of Melbourne Symposium on Cannabis 2-4 September (National Campaign Against Drug Abuse Monograph Series No. 7, pp. 19-24). Canberra: Australian Government Publishing Service
33. Jones, R.T., N.L. Benowitz, and R.I. Herning. 1981. Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21(8-9 Suppl):143S-152S
34. Joy, J.E., S.J. Watson, Jr., and J.A. Benson, Jr. 1999. Marijuana and medicine: Assessing the science base. Institute of Medicine. Washington, DC: National Academy Press
35. Lee, M.L., M. Novotny, and K.D. Bartle. 1976. Gas chromatography/mass spectrometric and nuclear magnetic resonance spectrometric studies of carcinogenic polynuclear aromatic hydrocarbons in tobacco and marijuana smoke condensates. Anal Chem 48(2):405-416
36. Liguori, A., Gatto, C.P., and J.H. Robinson. 1998. Effects of marijuana on equilibrium, psychomotor performance, and simulated driving. Behav Pharmacol 9(7):590-609
37. Lucas, V.S., Jr., and J. Laszlo. 1980. δ9-tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. J Amer Med Assoc 243(12):1241-1243
38. Mattes, R.D., L.M. Shaw, and K. Engelman. 1994. Effects of cannabinoids (marijuana) on taste intensity and hedonic ratings and salivary flow of adults. Chem Senses 19(2):125-140
39. McPartland, J.M. 2001. Contaminants and adulterants in herbal Cannabis. In: F. Grotenhermen, and E. Russo (eds.). Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential. Binghamton, NY: The Haworth Press, Inc., in press
40. Meinck, H.M., P.W. Schönle, and B. Conrad. 1989. Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol 236(2):120-122
41. Miller, W.E., R.E. Spiekerman, and N.G. Hepper. 1972. Pneumomediastinum resulting from performing Valsalva maneuvers during marihuana smoking. Chest 62(2): 233-234
42. Mutschler E. 1996. Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie. 7th edition, Stuttgart: Wissenschaftliche Verlagsgesellschaft, p. 192
43. Ohlsson, A., J.E. Lindgren, A. Wahlen, S. Agurell, L.E. Hollister, and H.K. Gillespie. 1980. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28(3): 409-416
44. O'Shaughnessy, W.B. 1838-1840. On the preparations of the Indian hemp or gunjah (Cannabis indica) Their effects on the animal system in health and their utility in the treatment of tetanus and other convulsive diseases. Transactions of the Medical and Physical Society of Bengal 1838-1840. Reprint in: Mikuriya, Tod H. ed. Marijuana: Medical Papers 1839-1972. Oakland: Medi-Comp Press, 1973
45. Perez-Reyes, M., M.A. Lipton, M.C. Timmons, M.E. Wall, D.R. Brine, and K.H. Davis. 1973. Pharmacology of orally administered δ9-tetrahydrocannabinol. Clin Pharmacol Ther 14(1):48-55
46. Perez-Reyes, M., S.M. Owens, and S. Di Guiseppi. 1981. The clinical pharmacology and dynamics of marihuana cigarette smoking. J Clin Pharmacol 21(8-9 Suppl): 201S-207S
47. Perlin, E., C.G. Smith, A.I. Nichols, R. Almirez, K.P. Flora, J.C. Cradock, and C.C. Peck. 1985. Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey. J Pharm Sci 74(2):171-174
48. Sherrill, D.L., M. Krzyzanowski, J.W. Bloom, and M.D. Lebowitz. 1991. Respiratory effects of non-tobacco cigarettes: A longitudinal study in general population. Int J Epidemiol 20(1):132-137
49. Solowij, N., P.T. Michie, and A.M. Fox. 1991. Effects of long-term cannabis use on selective attention: An event-related potential study. Pharmacol Biochem Behav 40(3):683-688
50. Sparacino, C.M., P.A. Hyldburg, and T.J. Hughes. 1990. Chemical and biological analysis of marijuana smoke condensate. NIDA Res Monogr 99:121-140
51. Stevens, R.A., and S.M. Ghazi. 2000. Routes of opioid analgesic therapy in the management of cancer pain. Cancer Control 7(2):132-141
52. Tashkin, D.P. 2001. Respiratory risks from marijuana smoking. In F. Grotenhermen, and E. Russo (eds.). Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential. Binghamton, NY: The Haworth Press, Inc., in press
53. Tashkin, D.P., F. Gliederer, J. Rose, P. Chang, K.K. Hui, J.L. Yu, and T.C. Wu. 1991. Tar, CO and delta 9-THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav 40(3):657-661
54. Tashkin, D.P., A.H. Coulson, V.A. Clark, M. Simmons, L.B. Bourque, S. Duann, G.H. Spivey, and H. Gong. 1987. Respiratory symptoms and lung function in habitual, heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Resp Disease 135:209-216
55. Touitou, E., B. Fabin, S. Dany, and S. Almog. 1988. Transdermal delivery of tetrahydrocannabinol. Int J Pharm 43:9-15
56. Touitou, E., and B. Fabin. 1988. Altered skin permeation of a highly lipophilic molecule: Tetrahydrocannabinol. Int J Pharm 43:17-22
57. Turner, C.E., M.A. Elsohly, and E.G. Boeren. 1980. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod 43(2):169-234
58. Ungerleider, J.T., T. Andrysiak, D.P. Tashkin, and R.P. Gale. 1982. Contamination of marihuana cigarettes with pathogenic bacteria-possible source of infection in cancer patients. Cancer Treat Rep 66(3):589-591
59. Vaughan, C.W., and M.J. Christie. 2001. Mechanisms of cannabinoid analgesia. In F. Grotenhermen, and E. Russo (eds.). Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential. Binghamton, NY: The Haworth Press, Inc., in press
60. Wall, M. E., B.M. Sadler, D. Brine, H. Taylor, and M. Perez-Reyes. 1983. Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 34(3):352-363
61. Wu, T.C., D.P. Tashkin, B. Djahed, and J.E. Rose. 1988. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 318(6):347-351
62. Zhang, Z.-F., H. Morgenstern, M.R. Spitz, D.P. Tashkin, G.-P. Yu, J.R. Marshall, T.C. Hsu, S.P. Schantz. 1999. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 8:1071-1079